Targeting CD19/CD20 Dual-targeted Cell in Patients With Relapsed/Refractory B-cell Non-Hodgkin Lymphoma
The First Affiliated Hospital with Nanjing Medical University
The First Affiliated Hospital with Nanjing Medical University
Roswell Park Cancer Institute
Thomas Jefferson University
920th Hospital of Joint Logistics Support Force of People's Liberation Army of China
Academic and Community Cancer Research United
Medical College of Wisconsin
Fred Hutchinson Cancer Center
Case Comprehensive Cancer Center
The Lymphoma Academic Research Organisation
Fred Hutchinson Cancer Center
Jonsson Comprehensive Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
M.D. Anderson Cancer Center
Cedars-Sinai Medical Center
M.D. Anderson Cancer Center
The Lymphoma Academic Research Organisation
Oncology Specialists, S.C.
Ohio State University Comprehensive Cancer Center
Stanford University
French Innovative Leukemia Organisation
City of Hope Medical Center
Gesellschaft fur Medizinische Innovation - Hamatologie und Onkologie mbH
Massachusetts General Hospital
Fondazione Italiana Linfomi - ETS
French Innovative Leukemia Organisation
Centre Leon Berard
Duke University
University of California, San Francisco
University of California, San Francisco
Nevada Cancer Institute
Hoosier Cancer Research Network
International Extranodal Lymphoma Study Group (IELSG)
Emory University
Gustave Roussy, Cancer Campus, Grand Paris